https://blogs.mercola.com:443/sites/vitalvotes/archive/2004/12/17/possible-cardiovascular-dangers-with-celebrex.aspxFirst, it was Vioxx . Then, it was Bextra . After today's announcement by Pfizer, it could be three strikes and Cox-2 inhibitors are OUT! Based on an analysis of a large, long-term cancer trial, Pfizer admitted Celebrex more than doubled one's risk ofenCommunityServer 2008.5 SP1 (Debug Build: 31106.3070)